| Revenue from operations also declined 6.79% quarter on quarter (QoQ) to Rs 2,410 crore for the quarter ended 30 June 2025
On a year-on-year (YoY) basis, the company’s net profit rose 26.74%, while revenue increased 13.78%, indicating continued growth over the previous year despite the sequential decline.
Profit before tax for the quarter stood at Rs 733 crore, down 15.16% QoQ but up 21.35% YoY.
The company reported a forex gain of Rs 39 crore during the quarter, compared to a forex loss of Rs 1 crore in the corresponding quarter of the previous financial year.
On a standalone basis, the company’s net profit surged 29.53% to Rs 557 crore on a 14.25% rise in revenue to Rs 2,357 crore in Q1 FY26 over Q1 FY25.
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
|